Romain KANIA

Prof. Dr. Romain KANIA

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2019 in The Journal of International Advanced Otology
Verified
Journal Article
Open access
JWJérôme Waterval
Jérôme Waterval
RKRomain KANIA
Romain KANIA
TSThomas Somers
Thomas Somers
Currently, cerebellopontine angle tumor and, more specifically, vestibular schwannoma is diagnosed using magnetic resonance imaging (MRI). The main reason to perform an MRI scan is to determine asymmetrical sensorineural hearing loss. The extent of asymmetry differs in the presentation of vestibular schwannoma, making it difficult to determine when to perform imaging diagnostics. Several studies have determined the probability of the presence of a cerebellopontine angle lesion using different audiological protocols. Further, there is also a cost aspect: what are the accepted sensitivity and specificity of these protocols? In this study, we reviewed the existing protocols. Cite this article as: Waterval JJ, Kania R, Somers T. EAONO Position Statement on Vestibular Schwannoma: Imaging Assessment. What are the Indications for Performing a Screening MRI Scan for a Potential Vestibular Schwannoma? J Int Adv Otol 2018; 14(1): xx.

26 February 2019 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
RKRomain KANIA
Romain KANIA
PVPierre Vironneau
Pierre Vironneau
HDHuong Dang
Huong Dang
BBBéatrice Bercot
Béatrice Bercot
ECEmmanuelle Cambau
Emmanuelle Cambau
TAThierry Van Den Abbeele
Thierry Van Den Abbeele
Biofilms are communities of bacteria embedded in a self-produced glycocalyx matrix. Adenoids have been shown to harbor bacterial biofilms. Aim/objectives: To compare the prevalence of biofilms in adenoid of children with chronic otitis media (COM) (group1) versus a control group without any COM (group 2) having adenoids removed because of hypertrophy. One hundred and three children were prospectively enrolled in this case-control study, group 1 (n = 52) and group 2 (n = 51). The main outcome measurement was the prevalence of biofilm in adenoidectomy specimens analyzed using confocal laser scanning microscopy. Children in group 1 who had middle ear (ME) effusion and requiring the insertion of a tympanostomy tube underwent biopsy of the ME mucosa and effusion sampling. Biofilms were found in adenoids' specimens of both groups and in the ME biopsy and effusion. The biofilm prevalence in adenoids was 63.5% (33/52) in group 1 and 47.1% (24/51) in group 2. Day nursery and previous antibiotics intake were significantly more frequent in group 1 than in group 2. This case-control study demonstrates that adenoid tissue in children with COM contains more mucosal biofilms than adenoid tissue removed for hypertrophy. Biofilm was seen in ME biopsies and effusion.

3 September 2019 in The Journal of International Advanced Otology
Verified
Journal Article
Open access
RKRomain KANIA
Romain KANIA
BVBenjamin Vérillaud
Benjamin Vérillaud
DCDomitille Camous
Domitille Camous
CHCharlotte Hautefort
Charlotte Hautefort
TSThomas Somers
Thomas Somers
PHPhilippe Herman
Philippe Herman
The relevance of defining the growth of vestibular schwannoma (VS) is that any significant VS growth may impact treatment strategy. A conservative treatment strategy is often proposed as a primary treatment option in the management of VS. Several authors have demonstrated that a significant proportion of VSs do not grow, and those that do, usually grow slowly. Surgical and/or radiosurgical treatment options may be offered to the patient according to the VS growth. Therefore, defining the VS growth is a determinant in managing treatment strategies. A comprehensive literature search was performed to examine the definition of tumor growth for VS. The literature review was conducted using PubMed and Embase databases dated back to 20 years (1995–2015) and was updated until February 2015. VS growth should be measured on contrast-enhanced T1-weighted images. Although there the overall quality of the present studies is low, all highlight a significant VS growth of >2 mm, and/or 1.2 cm3, and/or 20% change in volume, and/or the square of the product of the 2 orthogonal diameters. We suggest that VS growth should instead change management strategies when a 3-mm increase in diameter on two consecutive MRI scans are performed 1 year apart. Cite this article as: Kania R, Verillaud B, Camous D, Hautefort C, Somers T, Waterval JJ, et al. EAONO position statement on Vestibular Schwannoma:Imaging Assessment Question: How should growth of Vestibular Schwannoma be defined? J Int Adv Otol 2018; 14(1): xx.

3 September 2019 in The Journal of International Advanced Otology
Verified
Journal Article
Open access
TSThomas Somers
Thomas Somers
RKRomain KANIA
Romain KANIA
JWJérôme Waterval
Jérôme Waterval
THTony Van Havenbergh
Tony Van Havenbergh
The wait and scan policy is being increasingly used as the first measure after the diagnosis of a vestibular schwannoma (VS) using magnetic resonance imaging (MRI). As part of the European Academy of Otology & Neuro-Otology (EAONO) position statement on VS, the frequency of imaging has been studied in the literature. Among 163 studies, 29 fulfilled the inclusion criteria and were scored using the Grading of Recommendations, Assessment, Development, and Evaluation system. Because tumor growth rate during the first 5 years of follow-up is predictive of further growth during the upcoming years, a protocol for wait and scan is useful for centers dealing with this condition. The EAONO proposal is that after the initial diagnosis by MRI, a first new MRI would take place after 6 months, annually for 5 years, and then every other year for 4 years, followed by a lifelong MRI follow-up every 5 years. The first early MRI is to screen for fast-growing tumors, and the lifelong follow-up with tapered intervals is to detect late repeated growth. Cite this article as: Somers T, Kania R, Waterval J, Havenbergh TV. What is the Required Frequency of MRI Scanning in the Wait and Scan Management? J Int Adv Otol 2018; 14(1): 85-9.

8 November 2022 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
Alessandro VinciguerraAlessandro Vinciguerra
Alessandro Vinciguerra
JBJustine Bécaud
Justine Bécaud
NSNicolas Saroul
Nicolas Saroul
Thierry MomThierry Mom
Thierry Mom
VPVITO PONTILLO
VITO PONTILLO
BVBenjamin VERILLAUD
Benjamin VERILLAUD

12 February 2020 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
HJHervé Jacquier
Hervé Jacquier
PVPierre Vironneau
Pierre Vironneau
HDHuong Dang
Huong Dang
BVBenjamin Verillaud
Benjamin Verillaud
GLGerda Lamers
Gerda Lamers
RKRomain KANIA
Romain KANIA
Background: We previously described that adenoid tissue in children with chronic otitis media (COM) contained more mucosal biofilms than adenoid tissue removed for hypertrophy. Aims/objectives: The aim of the second part was to characterize nasopharyngeal microbiota and explore virulence of the most common middle ear pathogens. Material and methods: Bacteriological analysis was performed following a culture-based approach on the samples recovered from 30 patients of COM group (15 biofilm-positive and 15 biofilm-negative) and from 30 patients of a control group (15 biofilm-positive and 15 biofilm-negative). Virulence factors of Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae were investigated. Results: The most frequent species were Firmicutes followed by Proteobacteria and Actinobacteria. The presence of biofilm was statistically associated with an increase of the number of bacterial species and Firmicutes phylum regardless of the condition (case/control). No virulence factors associated with invasive isolates were found for the most common middle ear pathogens. Conclusions and significance: This case–control study demonstrated that the presence of COM plus biofilm was associated with a given microbiota which contained more Firmicutes. Our study allows a better understanding of physiopathological mechanisms involved in chronic otitis media and paves the way for further investigations.